Cellectar Biosciences
CLRB
CLRB
19 hedge funds and large institutions have $3.85M invested in Cellectar Biosciences in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$238K | |
| 2 | +$31.4K | |
| 3 | +$23.6K | |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$23.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.72K |
Top Sellers
| 1 | -$266K | |
| 2 | -$83K | |
| 3 | -$67.5K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$60K |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$48.8K |